Prospective assessment of antidonor cellular alloreactivity is a tool for guidance of immunosuppression in kidney transplantation

Kidney International

Volumn 84, Issue 6, 2013, Pages 1226-1236

  Bestard, Oriol ^a,b   Cruzado, Josep M ^a,b   Lucia, Marc ^b   Crespo, Elena ^b   Casis, Linda ^b   Sawitzki, Birgit ^c   Vogt, Katrin ^c   Cantarell, Carme ^d   Torras, Joan ^a,b   Melilli, Edoardo ^a   Mast, Richard ^a   Martinez Castelao, Alberto ^a   Gomà, Montse ^a   Reinke, Petra ^c   Volk, Hans Dieter ^c   Grinyó, Josep M ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

effector memory T cells; IFN Elispot; immune monitoring; kidney transplantation

Indexed keywords

CALCINEURIN INHIBITOR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ALLOIMMUNITY; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMETHYLATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; IMMUNOREGULATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE;

ADULT; BIOLOGICAL MARKERS; BIOPSY; DNA METHYLATION; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; ISOANTIGENS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; T-LYMPHOCYTES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84888640668     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.236     Document Type: Article

References (36)

1. Nankivell BJ, Borrows RJ, Fung CL et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-2333.
2. Meier-Kriesche HU, Ojo AO, Leichtman AB et al. Interaction of mycophenolate mofetil and HLA matching on renal allograft survival. Transplantation 2001; 71: 398-401.
3. Lodhi SA, Lamb KE, Meier-Kriesche HU. Solid organ allograft survival improvement in the United States: The long-term does not mirror the dramatic short-term success. Am J Transplant 2011; 11: 1226-1233.
4. Bestard O, Cruzado JM, la Franquesa M et al. Biomarkers in renal transplantation. Curr Opin Organ Transplant 2010; 15: 467-473.
5. Sawitzki B, Schlickeiser S, Reinke P et al. Monitoring tolerance and rejection in organ transplant recipients. Biomarkers 2011; 16(Suppl 1): S42-S50.
6. Amir AL, D'Orsogna LJ, Roelen DL et al. Allo-HLA reactivity of virusspecific memory T cells is common. Blood 2010; 115: 3146-3157.
7. Heeger PS. T-cell allorecognition and transplant rejection: A summary and update. Am J Transplant 2003; 3: 525-533.
8. Issa F, Schiopu A, Wood KJ. Role of T cells in graft rejection and transplantation tolerance. Expert Rev Clin Immunol 2010; 6: 155-169.
9. Valujskikh A. Memory T cells in allograft rejection. Adv Exp Med Biol 2007; 601: 247-256.
10. Pearl JP, Parris J, Hale DA et al. Immunocompetent T-cells with a memorylike phenotype are the dominant cell type following antibody-mediated T cell depletion. Am. J. Transplant 2005; 5: 465-474.
11. Trzonkowski P, Zilvetti M, Chapman S et al. Homeostatic repopulation by CD28-CD8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression. Am J Transplant 2008; 8: 338-347.
12. Adams AB, Williams MA, Jones TR et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003; 111: 1887-1895.
13. Bestard O, Cassis L, Cruzado JM et al. Costimulatory blockade with mor inhibition abrogates effector T-cell responses allowing regulatory T-cell survival in renal transplantation. Transplant Int 2011; 24: 451-460.
14. Gebauer BS, Hricik DE, Atallah A et al. Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant 2002; 2: 857-866.
15. Augustine JJ, Siu DS, Clemente MJ et al. Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients. Am J Transplant 2005; 5: 1971-1975.
16. Bestard O, Cruzado JM, Mestre M et al. Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. J Immunol 2007; 179: 4901-4909.
17. Nickel P, Presber F, Bold G et al. Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients. Transplantation 2004; 78: 1640-1646.
18. Andree H, Nickel P, Nasiadko C et al. Identification of dialysis patients with panel-reactive memory T cells before kidney transplantation using an allogeneic cell bank. J Am Soc Nephrol 2006; 17: 573-580.
19. Augustine JJ, Poggio ED, Clemente M et al. Hemodialysis vintage, black ethnicity, and pretransplantation antidonor cellular immunity in kidney transplant recipients. J Am Soc Nephrol 2007; 18: 1602-1606.
20. Poggio ED, Augustine JJ, Clemente M et al. Pretransplant cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection. Transplantation 2007; 83: 847-852.
21. Bestard O, Nickel P, Cruzado JM et al. Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients. J Am Soc Nephrol 2008; 19: 1419-1429.
22. Ekberg H, Tedesco-Silva H, Demirbas A et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562-2575.
23. Gebuhr I, Keeren K, Vogt K et al. Differential expression and function of a-mannosidase I in stimulated naive and memory CD4+ T cells. J Immunother 2011; 34: 428-437.
24. Keeren K, Friedrich M, Gebuhr I et al. Expression of tolerance associated gene-1, a mitochondrial protein inhibiting T cell activation, can be used to predict response to immune modulating therapies. J Immunol 2009 15; 183: 4077-4087.
25. Baron U, Floess S, Wieczorek G et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+)conventional T cells. Eur J Immunol 2007; 37: 2378-2389.
26. Sehouli J, Loddenkemper C, Cornu T et al. Epigenetic quantification of tumor-infiltrating T-lymphocytes. Epigenetics 2011; 6: 236-246.
27. Lebranchu Y, Thierry A, Toupance O et al. Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: Concept study. Am J Transplant 2009; 9: 1115-1123.
28. Sharif A, Shabir S, Chand S et al. Meta-Analysis of calcineurin- inhibitorsparing regimens in kidney transplantation. J Am Soc Nephrol 2011; 22: 2107-2118.
29. Noris M, Casiraghi F, Todeschini M et al. Regulatory T cells and T cell depletion: Role of immunosuppressive drugs. J Am Soc Nephrol 2007; 18: 1007-1018.
30. Bestard O, Stein M, Roelen R et al. Interlab crossvalidation of IFN-c Elispot assay for measuring alloreactive memory/effector T-cell responses in renal transplant recipients. Am J Transplant 2013 (in press).
31. Heeger PS, Greenspan NS, Kuhlenschmidt S et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999; 163: 2267-2275.
32. Baxter-Lowe L. HLA-DR sequence-based typing. In: Noreen H (eds) ASHI Laboratory Manual, Vol 2. 4th edn, American Society of Histocompatibility and Immunogenetics 2000; V.C.8. 1.
33. Gebel HM, Bray RA. Sensitization and sensitivity: Defining the unsensitized patient. Transplantation 2000; 69: 1370-1374.
34. Sis B, Mengel M, Haas M et al. Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464-471.
35. Sagoo P, Perucha E, Sawitzki B et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 2010; 120: 1848-1861.
36. Wieczorek G, Asemissen A, Model F et al. Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res 2009; 69: 599-608.